法尼甾体X受体
胆固醇7α羟化酶
肝肠循环
胆汁酸
胆酸
回肠
CYP8B1
G蛋白偶联胆汁酸受体
鹅去氧胆酸
FGF19型
内科学
肠道菌群
新陈代谢
生物
胆酸
核受体
脱氧胆酸
生物化学
内分泌学
受体
成纤维细胞生长因子
医学
转录因子
基因
作者
Pablo Quintero,Marco Arrese
出处
期刊:Hepatology
[Lippincott Williams & Wilkins]
日期:2013-06-14
卷期号:58 (5): 1850-1853
被引量:4
摘要
Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, et al . Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013;17:225-235. (Reprinted with permission). Abstract Bile acids are synthesized from cholesterol in the liver and further metabolized by the gut microbiota into secondary bile acids. Bile acid synthesis is under negative feedback control through activation of the nuclear receptor farnesoid X receptor (FXR) in the ileum and liver. Here we profiled the bile acid composition throughout the enterohepatic system in germfree (GF) and conventionally raised (CONV-R) mice. We confirmed a dramatic reduction in muricholic acid, but not cholic acid, levels in CONV-R mice. Rederivation of Fxr-deficient mice as GF demonstrated that the gut microbiota regulated expression of fibroblast growth factor 15 in the ileum and cholesterol 7a-hydroxylase (CYP7A1) in the liver by FXR-dependent mechanisms. Importantly, we identified tauroconjugated beta- and alpha-muricholic acids as FXR antagonists. These studies suggest that the gut microbiota not only regulates secondary bile acid metabolism but also inhibits bile acid synthesis in the liver by alleviating FXR inhibition in the ileum.
科研通智能强力驱动
Strongly Powered by AbleSci AI